These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase. Lv L; Jiang SS; Xu J; Gong JB; Cheng Y Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361 [TBL] [Abstract][Full Text] [Related]
4. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258 [TBL] [Abstract][Full Text] [Related]
5. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury. Pernow J; Wang QD Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551 [TBL] [Abstract][Full Text] [Related]
6. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Liu YN; Zhou ZM; Chen P Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891 [TBL] [Abstract][Full Text] [Related]
7. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403 [TBL] [Abstract][Full Text] [Related]
8. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727 [TBL] [Abstract][Full Text] [Related]
10. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Hamid SA; Bower HS; Baxter GF Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294 [TBL] [Abstract][Full Text] [Related]
12. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart. Faghihi M; Mirershadi F; Dehpour AR; Bazargan M Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320 [TBL] [Abstract][Full Text] [Related]
13. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926 [TBL] [Abstract][Full Text] [Related]
14. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits. Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190 [TBL] [Abstract][Full Text] [Related]